Weight-loss drug market seen reaching $100 billion as oral pills gain ground
AI Summary- Novo Nordisk and Eli Lilly are competing with other companies to develop weight-loss drugs.
- Analysts expect the sector to generate about $100 billion in annual sales within the next decade.
- Wegovy and Foundayo pills have received approvals in Europe or the United States.